Abby Care Raises $82M Series C to Pay Family Caregivers

The deal

Abby Care, a San Francisco home care startup, has raised an $82 million Series C. Transformation Capital led the round.1113 Fortune broke the news as an exclusive. Coverage elsewhere, including trade press and venture-data outlets, has repeated Fortune's details almost exactly. That means the core facts are consistent, though most of them trace back to one original report.3811

The investor list is the most informative part of the announcement. CVS Health Ventures, Frist Cressey Ventures and Pivotal Ventures are new to the company. Khosla Ventures, Thrive Capital and Sequoia, which were already investors, put in more money.311 The round follows a $35 million raise in August 2025.11 At $82 million, it ranks among the larger startup financings, and investors appear to believe that informal family caregiving can be turned into certified, paid work at scale.8

What Abby Care actually sells

Abby Care is not a scheduling app or a caregiver marketplace. It is a Medicaid provider. It trains family members to become certified nursing assistants or home health aides for relatives who qualify for in-home care, then pays them for that work.11 The patients include children, older adults and people with disabilities.11 Forbes covered the company in July and described the mechanics. Caregivers become Abby Care employees. The company collects Medicaid money through insurers and passes wages on to the caregivers. In Colorado, that pay is at least $20 an hour.7

The training combines online lessons for state certification with two days in person covering skills such as CPR. Each caregiver then builds a care plan with one of roughly 80 staff nurses.7 After that, an app handles timesheets, medical charting and an AI assistant that answers caregivers' questions.7 The company says the same tools document care and report it to health systems and health plans.11

Abby Care currently pays caregivers through Medicaid in eight states: Colorado, Florida, Georgia, Indiana, Massachusetts, New Jersey, Pennsylvania and Tennessee.11

Why a health insurer is in the round

CVS Health Ventures is the investor to watch. Justin Brock, a general partner there, explained the investment in terms of supply. He said traditional private-duty nursing programs fill only about 65% of authorized shifts, which leaves many medically complex patients without steady coverage. Meanwhile, tens of millions of relatives are already providing care at home.38 Commentators reached similar conclusions. One argued that Medicaid-funded home care directly affects an insurer's own costs.13 Another noted that health plans have reason to keep members out of expensive institutional care.12

In my reading, this is the main point of the round. Generalist growth investors were already on board. Adding a corporate payer arm and healthcare-focused specialists such as Transformation Capital and Frist Cressey suggests the next stage depends on contracts with payers and regulators as much as on software. Pivotal Ventures, Melinda French Gates' firm, has repeatedly backed care-economy investing, including as an anchor investor in the care-focused fund Magnify Ventures.13 Its participation reflects the fact that unpaid caregiving falls disproportionately on women and families.12

Founder and CEO Havi Nguyen describes the opportunity in terms of a reactive health system. On LinkedIn, she pointed to a shrinking healthcare workforce, an aging population and waitlists of vulnerable children. She also argued that clinicians cannot see what happens in the home, so health problems go unnoticed until they become emergencies.11 The company says it aims to cut unnecessary nursing hours, catch problems early enough to prevent hospitalizations, and avoid moving patients into institutions.11

The valuation question

The financial picture is incomplete. Neither Abby Care nor its investors disclosed a post-money valuation for the Series C. One venture-analysis outlet pointed out that revenue, valuation and the number of certified caregivers were all withheld, leaving the $82 million as the only confirmed figure.13

Earlier data offers rough benchmarks, but the sources disagree. Dealroom lists the August 2025 round as $35 million at a $140 million valuation and puts the company in a $100 million to $250 million valuation range.2 Forbes, writing this summer, said Abby Care had raised $45 million in total, most recently at a $225 million valuation. It also reported $15 million in revenue for the previous year.7 CB Insights recorded the $35 million round as a Series B and total funding of $35 million.5

The sources also differ on when the company was founded. Recent funding coverage says 2022.81213 Dealroom and CB Insights say 2021.25 Forbes said Nguyen started the company five years ago.7 These discrepancies are common in private-company data, but they mean any valuation estimate for this round is speculation.

Taking Forbes' figures, Abby Care raised nearly twice its previous total funding in one round, about a year after its last raise. Forbes also put the company on its 2026 Next Billion-Dollar Startups list, which picks companies it considers likely to reach a $1 billion valuation.7 My reading is that an $82 million Series C led by a specialist healthcare investor fits that trajectory. Without a disclosed price, though, it does not show the company has reached it.

Signs of traction

The operating metrics come mostly from the company and are hard to verify. Dealroom's profile says caregivers on the platform have delivered 1.9 million hours of care. It also says families report a 38% drop in hospitalizations after 120 days.2 The same profile counts about 352 employees.2 Crunchbase lists a much smaller headcount band, which suggests the databases are updated at different times.4

Personal stories appear throughout the coverage. One Colorado mother whose daughter needed open-heart surgery and a pacemaker said she became a certified paid caregiver through Abby Care. She said many families do not know they can be paid to care for their own medically complex children.615 Nguyen's own story appears in nearly every report. She grew up translating at doctors' appointments and handling Medicaid paperwork for her family after they immigrated from Vietnam. She later saw shortages of therapists and high turnover while working at an autism-therapy startup during the pandemic.815

Where the coverage diverges: risk

The reports agree on what Abby Care does but differ on how much risk it carries. Fortune-derived coverage mostly describes a large opportunity and lists competition as the main concern. Brock named incumbent home health agencies and caregiver-education platforms as the likely rivals.813 One analysis argued that the lack of a directly comparable venture-backed competitor helps explain why investors backed a round this large.12

Forbes was more cautious. It noted that being so closely tied to Medicaid exposes the company to sudden policy changes. President Trump's One Big Beautiful Bill included more than $1 trillion in healthcare budget cuts and new Medicaid eligibility restrictions. Forbes also reported that Colorado and Indiana, both Abby Care markets, have proposed cutting pay for family caregivers.7 Value Add's analysis agreed. It argued that the key due-diligence question is how concentrated the company's reimbursement is by state, not how large the overall market is.13

I find the policy risk more important than the competitive one. A rival can be outspent. A state budget cut cannot. Nguyen told Forbes that 37 states support the type of family care Abby Care provides, while the company operates in only eight.7 That gap is the expansion opportunity investors are funding. It also shows how much of the company's future depends on decisions made by state legislatures.

There is also a reputational risk. Medicaid-billing home care has long drawn scrutiny over fraud. Sequoia's investor told Forbes that the app's digital charting requirements help Abby Care guard against it.7 A reader comment beneath the Forbes profile, from a skeptic who described a bad experience with a different provider, shows the public doubts the sector still faces.7

What it signals for venture funding

Abby Care is part of a wider shift in where venture money goes. Several outlets describe it as an "AI-native" company, a label usually given to model labs and developer tools.612 Here, however, the AI is used to cut administrative costs in a regulated, labor-heavy service. Investors also appear to be favoring Medicaid- and insurance-reimbursed care models over cash-pay consumer health apps.13 In September, CVS Health Ventures also joined Thyme Care's $125 million Series E, which valued the cancer-navigation company at $2 billion.13

Thrive's Nworah Ayogu told Forbes that Abby Care's AI-forward approach makes a large difference, because its software lets caregivers "operate at a new level."7 The Series C will test that claim. If the software can handle Medicaid rules that vary from state to state as cheaply as the pitch suggests, Abby Care could look like a scalable platform. If not, it risks being a well-funded home care agency that still depends on state budgets.